PanCareSurPass Project HL7 FHIR Implementation Guide
0.1.0 - trial-use 150

This page is part of the PanCareSurPass Project HL7 FHIR Implementation Guide (v0.1.0: QA Preview) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ValueSet: Conditions at risk

Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-riskcondition-eu-pcsp Version: 0.1.0
Active as of 2023-01-26 Computable Name: RiskCondition

Condition at risk proposed by the PCSP algorithm

References

Logical Definition (CLD)

 

Expansion

This value set contains 47 concepts

Expansion based on PCSP Conditions at risk v0.1.0 (CodeSystem)

CodeSystemDisplayDefinition
  1http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent thyroid cancer

Subsequent thyroid cancer

  2http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent breast cancer

Subsequent breast cancer

  3http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)

Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)

  4http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspImpaired fertility Impaired spermatogenesis

Impaired fertility Impaired spermatogenesis

  5http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspTestosterone deficiency

Testosterone deficiency

  6http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspPhysical sexual dysfunction

Physical sexual dysfunction

  7http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspPremature ovarian insufficiency

Premature ovarian insufficiency

  8http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspEar problems

Ear problems

  9http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspImpaired glucose metabolism and diabetes melitus

Impaired glucose metabolism and diabetes melitus

  10http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspDyslipidemia

Dyslipidemia

  11http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspOverweight and obesity

Overweight and obesity

  12http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspHypertension

Hypertension

  13http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspReduced bone mineral density

Reduced bone mineral density

  14http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspOsteonecrosis

Osteonecrosis

  15http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspHypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)

Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)

  16http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspHypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)

Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)

  17http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCentral precocious puberty (CPP) For girls with age below 8 years

Central precocious puberty (CPP) For girls with age below 8 years

  18http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCentral precocious puberty (CPP) For boys with age below 9 yearss

Central precocious puberty (CPP) For boys with age below 9 yearss

  19http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspThyroid function problems

Thyroid function problems

  20http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCerebrovascular problem

Cerebrovascular problem

  21http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspNeurocognitive problems

Neurocognitive problems

  22http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspPeripheral neuropathy

Peripheral neuropathy

  23http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCataract

Cataract

  24http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspEye problems

Eye problems

  25http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCraniofacial growth problems

Craniofacial growth problems

  26http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSpine scoliosis and kyphosis

Spine scoliosis and kyphosis

  27http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspLower urinary tract problems

Lower urinary tract problems

  28http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspObstetric problems

Obstetric problems

  29http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspDental and oral problems

Dental and oral problems

  30http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspGastro-intestinal problems

Gastro-intestinal problems

  31http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspArrhythmia

Arrhythmia

  32http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspPulmonary problems

Pulmonary problems

  33http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspRenal problems (Glomerular dysfunction - Tubular dysfunction)

Renal problems (Glomerular dysfunction - Tubular dysfunction)

  34http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspLiver problems

Liver problems

  35http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspIron overload

Iron overload

  36http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSpleen problems

Spleen problems

  37http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspTumor predisposition

Tumor predisposition

  38http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent melanoma and non-melanoma skin cancer

Subsequent melanoma and non-melanoma skin cancer

  39http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent colorectal cancer

Subsequent colorectal cancer

  40http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent Oral Cancer

Subsequent Oral Cancer

  41http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent acute myeloid leukaemia or myelodysplasia

Subsequent acute myeloid leukaemia or myelodysplasia

  42http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent bladder cancer

Subsequent bladder cancer

  43http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent Bone Cancer

Subsequent Bone Cancer

  44http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent lung cancer

Subsequent lung cancer

  45http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspSubsequent CNS neoplasms

Subsequent CNS neoplasms

  46http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspCardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)

Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)

  47http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcspRenal problems (Tubular dysfunction)

Renal problems (Tubular dysfunction)


Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code